US EditionPivoting Paths: Key Developments in Health Sector
UNITED STATES, JUL 17 – The Eliquis 360 Support program offers uninsured and underinsured U.S. patients a 40% discount and direct home shipping to improve access and reduce out-of-pocket costs.
- Bristol Myers Squibb and Pfizer announced on July 17, 2025, a new direct-to-patient program to sell Eliquis at a discount across the U.S. and Puerto Rico.
- The program responds to government pressure under the Trump administration to lower drug prices by bypassing insurers and pharmacy benefit managers.
- Starting September 8, 2025, uninsured, underinsured, or self-pay patients can purchase Eliquis at $346 monthly through Eliquis 360 Support, down from the $606 list price.
- Eliquis, approved in 2012 and prescribed to over 15 million Americans, earned over $3 billion in sales in Q4 2024, with the drug also generating estimated $3 billion in healthcare savings per 100,000 patients.
- This initiative aims to improve access and affordability, but risks remain regarding the program's impact on Pfizer's business and competition from Medicare's negotiated Eliquis price of $231 starting next year.
19 Articles
19 Articles
Pivoting Paths: Key Developments in Health Sector
Pivoting Paths: Key Developments in Health Sector In a bid to make medications more accessible, Bristol Myers and Pfizer have announced a plan to offer their blood thinner Eliquis at reduced prices directly to U.S. patients without insurance. This decision comes amid mounting pressure from government officials on pharmaceutical companies to lower drug costs. However, health experts caution that the relief may still be insufficient for many who a…
Major drugmakers offer big discount on blood thinner Eliquis
Bristol Myers Squibb and Pfizer are offering an insurance-free pathway to access one of their widely used blood thinners. The pharmaceutical giants launched a new direct-to-patient option for purchasing Eliquis, the brand name for apixaban, through its Alliance’s patient resource Eliquis 360 Support, in an effort to expand patient access. Starting Sept. 8, eligible U.S. patients that are uninsured, underinsured or seek to pay out-of-pocket, can …
NBC Chicago
Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount
The companies’ new effort would bypass traditional middlemen to cut the drug’s monthly cost from a list price of around $606 to $346.
Coverage Details
Bias Distribution
- 63% of the sources are Center
To view factuality data please Upgrade to Premium
